| Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. Grier J.T., Forbes L.R., Monaco-Shawver L., Oshinsky J., Atkinson T.P., Moody C., Pandey R., Campbell K.S., Orange J.S.
J. Clin. Invest. 122:3769-3780(2012) · Mapped (5) |
| Critical role of macrophages and their activation via MyD88-NFkappaB signaling in lung innate immunity to Mycoplasma pneumoniae. Lai J.F., Zindl C.L., Duffy L.B., Atkinson T.P., Jung Y.W., van Rooijen N., Waites K.B., Krause D.C., Chaplin D.D.
PLoS ONE 5:e14417-e14417(2010) · Mapped (33) |
| Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. Bi L.L., Pan G., Atkinson T.P., Zheng L., Dale J.K., Makris C., Reddy V., McDonald J.M., Siegel R.M., Puck J.M. et al.
BMC Med. Genet. 8:41-41(2007) · Mapped (3) |
| Splice variant in TCRzeta links T cell receptor signaling to a G-protein-related signaling pathway. Atkinson T.P., Hall C.G., Goldsmith J., Kirkham P.M.
Biochem. Biophys. Res. Commun. 310:761-766(2003) · Mapped (5) |
| Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M., Dale J.K., Puck J., Davis J., Hall C.G. et al.
Nature 419:395-399(2002) · UniProtKB (1) · Mapped (1) |
| A novel type II complement C2 deficiency allele in an African-American family. Zhu Z.B., Atkinson T.P., Volanakis J.E.
J. Immunol. 161:578-584(1998) · UniProtKB (1) |
| Translocation of phospholipase C-gamma 2 induced by in vitro activation of protein tyrosine kinase activity in mast cell lysates. Atkinson T.P., Yang Q.
Cell. Signal. 8:461-465(1996) · Mapped (2) |
